These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23974694)

  • 21. Novel biological immunotherapies for psoriasis.
    Kanitakis J; Butnaru AC; Claudy A
    Expert Opin Investig Drugs; 2003 Jul; 12(7):1111-21. PubMed ID: 12831347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of calcitriol on the production of T-cell-derived cytokines in psoriasis.
    Barna M; Bos JD; Kapsenberg ML; Snijdewint FG
    Br J Dermatol; 1997 Apr; 136(4):536-41. PubMed ID: 9155954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokine targeting in psoriasis and psoriatic arthritis: beyond TNFalpha.
    MclInnes IB
    Ernst Schering Res Found Workshop; 2006; (56):29-44. PubMed ID: 16329645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alefacept for the treatment of psoriasis and other dermatologic diseases.
    Strober BE; Menon K
    Dermatol Ther; 2007; 20(4):270-6. PubMed ID: 17970892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of adalimumab in plaque psoriasis: experience on 28 patients.
    Ardigò M; Giuliani A; de Felice C; Mastroianni A; Berardesca E
    J Drugs Dermatol; 2008 Oct; 7(10):935-9. PubMed ID: 19112756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biologic agents in psoriasis.
    Lee MR; Cooper AJ
    Australas J Dermatol; 2006 Nov; 47(4):217-29; quiz 229-30. PubMed ID: 17034462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apremilast mechanism of action and application to psoriasis and psoriatic arthritis.
    Schafer P
    Biochem Pharmacol; 2012 Jun; 83(12):1583-90. PubMed ID: 22257911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential immunologic targets for treating fibrosis in systemic sclerosis: a review focused on leukocytes and cytokines.
    Hasegawa M; Takehara K
    Semin Arthritis Rheum; 2012 Dec; 42(3):281-96. PubMed ID: 22542279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New treatments for psoriasis: which biologic is best?
    Nelson AA; Pearce DJ; Fleischer AB; Balkrishnan R; Feldman SR
    J Dermatolog Treat; 2006; 17(2):96-107. PubMed ID: 16766334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biologic therapies for psoriasis.
    de Felice C; Ardigo M; Berardesca E
    J Rheumatol Suppl; 2009 Aug; 83():62-4. PubMed ID: 19661545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of biologicals in psoriasis].
    Friedrich M; Philipp S; Sabat R; Asadullah K; Sterry W
    Z Rheumatol; 2003 Oct; 62(5):439-49. PubMed ID: 14579031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Future perspectives in the treatment of psoriasis: news in biological therapies].
    Diamantino F; Ferreira A
    Acta Med Port; 2011; 24(6):997-1004. PubMed ID: 22713194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-signaling molecules in psoriasis pathogenesis: implications for targeted therapy.
    Lin X; Huang T
    Hum Immunol; 2015 Mar; 76(2-3):95-101. PubMed ID: 25636578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemokine receptors in the pathogenesis and therapy of psoriasis.
    Mabuchi T; Chang TW; Quinter S; Hwang ST
    J Dermatol Sci; 2012 Jan; 65(1):4-11. PubMed ID: 22177422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alefacept treatment for chronic plaque psoriasis.
    Dunn LK; Feldman SR
    Skin Therapy Lett; 2010 Apr; 15(4):1-3. PubMed ID: 20361167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the Th17 pathway in psoriasis.
    Elloso MM; Gomez-Angelats M; Fourie AM
    J Leukoc Biol; 2012 Dec; 92(6):1187-97. PubMed ID: 22962689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach.
    Späh F
    Br J Dermatol; 2008 Aug; 159 Suppl 2():10-7. PubMed ID: 18700910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small Molecules in the Treatment of Psoriasis.
    Torres T; Filipe P
    Drug Dev Res; 2015 Aug; 76(5):215-27. PubMed ID: 26255795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenesis and treatment of psoriasis: exploiting pathophysiological pathways for precision medicine.
    Alwan W; Nestle FO
    Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S2-6. PubMed ID: 26472336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Targeted therapy in inflammatory disease: cytokines].
    von Frenckell C; Malaise MG
    Rev Med Liege; 2012; 67 Spec No():22-8. PubMed ID: 22690482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.